Expanded Access for Bulevirtide
NCT06780579
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis Delta Virus Infection
Interventions
DRUG:
Bulevirtide
Sponsor
Gilead Sciences